Association of metformin use and survival in patients with cutaneous melanoma and diabetes.

Krakowski, Isabelle; Häbel, Henrike; Nielsen, Kari; Ingvar, Christian; Andersson, Therese M L; Girnita, Ada; Smedby, Karin E; Eriksson, Hanna

Krakowski, Isabelle; Häbel, Henrike; Nielsen, Kari; Ingvar, Christian; Andersson, Therese M L; Girnita, Ada; Smedby, Karin E; Eriksson, Hanna.

Afiliação

Krakowski I; Department of Dermatology/Inflammation Theme.
Häbel H; Department of Oncology and Pathology.
Nielsen K; Institute of Environmental Medicine.
Ingvar C; Dermatology and Department of Dermatology, Skåne University Hospital, Lund, Sweden.
Andersson TML; Surgery, Department of Clinical Sciences, Lund University, Lund, Sweden.
Girnita A; Department of Medical Epidemiology and Biostatistics.
Smedby KE; Department of Oncology and Pathology.
Eriksson H; Cancer Theme, Medical Unit Head, Neck, Lung and Skin Cancer, Skin Cancer Center.

Br J Dermatol ; 188(1): 32-40, 2023 01 23.

Article em En | MEDLINE | ID: mdl-36689497

Assuntos

Diabetes Mellitus Tipo 2; Melanoma; Metformina; Neoplasias Cutâneas; Adulto; Humanos; Hipoglicemiantes; Estudos de Coortes; Estudos Retrospectivos; Melanoma Maligno Cutâneo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Diabetes Mellitus Tipo 2 / Melanoma / Metformina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google